Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 3.660E-09 | 7.969E-05 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 4.017E-08 | 4.276E-04 | CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 8.300E-08 | 4.518E-04 | CA12, CA4, CA7 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 2.417E-07 | 1.053E-03 | CYP2C19, CYP2C9, CYP3A4, HSD17B2, NPC1 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 1.084E-06 | 2.951E-03 | CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.293E-06 | 3.128E-03 | CA12, CA4, CA7 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 2.121E-06 | 4.199E-03 | CYP2C9, CYP3A4 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 2.392E-06 | 4.291E-03 | CA12, CA4, CA7 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 2.561E-06 | 4.291E-03 | CYP2C19, CYP2C9, CYP3A4 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.117E-07 | 2.681E-06 | CA12; CA4; CA7 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 5.977E-07 | 7.173E-06 | CYP2C9; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 7.059E-06 | 5.073E-05 | CYP2C9; ALDH1A1; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 8.456E-06 | 5.073E-05 | CYP2C9; CYP3A4; CYP2C19 |
hsa05204 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.423E-05 | 6.830E-05 | CYP2C9; CYP3A4; CYP2C19 |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 4.965E-04 | 1.835E-03 | CYP2C9; HSD17B2; ALDH1A1; CYP2C19; CYP3A4 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 6.117E-04 | 1.835E-03 | CYP2C9; CYP2C19 |
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 5.354E-04 | 1.835E-03 | HSD17B2; CYP3A4 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 8.470E-04 | 2.259E-03 | CYP2C9; CYP3A4 |
hsa04726 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.978E-03 | 4.746E-03 | CYP2C9; CYP2C19 |
hsa04964 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.372E-02 | 2.993E-02 | CA4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
C00-D49: Neoplasms | Lymphoma | C81-C86 | HIF1A |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA4 |
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | RAB9A |
C00-D49: Neoplasms | Cancer | C00-C96 | HIF1A |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | CYP3A4 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | HIF1A |
H00-H59: Diseases of the eye and adnexa | Ocular hypertension | H40.0 | CA4; CA4 |
I00-I99: Diseases of the circulatory system | Pulmonary arterial hypertension | I27.0, I27.2 | HIF1A |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |